CPAP IMPROVES ENDOTHELIAL FUNCTION IN MINIMALLY SYMPTOMATIC OSA PATIENTS: RESULTS FROM THE MOSAIC TRIAL

CPAP IMPROVES ENDOTHELIAL FUNCTION IN MINIMALLY SYMPTOMATIC OSA PATIENTS: RESULTS FROM THE MOSAIC TRIAL

Bibliographic Details
Main Authors:	Kohler, M, Craig, SE, Pepperell, J, Nicoll, D, Bratton, D, Nunn, A, Davies, R, Stradling, JR
Format:	Conference item
Published:	2010

Similar Items

CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial.
by: Kohler, M, et al.
Published: (2013)

THE PRIMARY RESULTS OF THE MOSAIC TRIAL: DOES CPAP FOR MINIMALLY SYMPTOMATIC OSA REDUCE DAYTIME SLEEPINESS OR CALCULATED VASCULAR RISK?
by: Craig, SE, et al.
Published: (2010)

Effect of CPAP on cardiac function in minimally symptomatic patients with OSA: results from a subset of the MOSAIC randomized trial
by: Craig, S, et al.
Published: (2015)

Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA
by: Craig, S, et al.
Published: (2014)

Patterns of CPAP usage in patients with minimally symptomatic OSA
by: Turnbull, C, et al.
Published: (2015)

In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP
by: Turnbull, CD, et al.
Published: (2016)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
by: Tang, I, et al.
Published: (2020)

In minimally symptomatic OSA what is the best test to measure CPAP response?
by: Turnbull, C, et al.
Published: (2015)

CPAP and measures of cardiovascular risk in males with OSAS.
by: Kohler, M, et al.
Published: (2008)

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
by: Craig, SE, et al.
Published: (2012)

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
by: Craig, SE, et al.
Published: (2012)

Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea.
by: Kohler, M, et al.
Published: (2008)

Residual sleepiness in patients with OSA on CPAP.
by: Stradling, JR
Published: (2009)

Mild To Moderate, Minimally Symptomatic, Obstructive Sleep Apnoea (OSA) Is Associated With 'Vulnerable' Carotid Atherosclerotic Plaques
by: Craig, SE, et al.
Published: (2010)

Predictors of continuous positive airways pressure usage at six months in minimally symptomatic patients: further data from the MOSAIC trial.
by: Turnbull, C, et al.
Published: (2015)

ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
by: Schlatzer, C, et al.
Published: (2016)

Blood pressure change after treatment for obstructive sleep apnoea (OSA) with continuous positive airway pressure (CPAP)
by: Pepperell, J, et al.
Published: (2000)

Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials.
by: Bratton, D, et al.
Published: (2014)

Relative accuracy of algorithm-based prescription of nasal CPAP in OSA.
by: Stradling, JR, et al.
Published: (2004)

A novel, simplified approach to starting nasal CPAP therapy in OSA.
by: Stradling, JR, et al.
Published: (2004)

Metabolic Sydrome Prediction in Mild/Moderate OSA Patients - Anthropometric Measures and Abdominal Fat Estimations by MRI
by: Craig, SE, et al.
Published: (2009)

Circulating Cell-Derived Microparticles in Patients with Minimally Symptomatic Obstructive Sleep Apnea
by: Kohler, M, et al.
Published: (2009)

Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea.
by: Ayers, L, et al.
Published: (2009)

The effects of CPAP withdrawal in patients with OSA on hypoxia-induced markers
by: Turnbull, C, et al.
Published: (2016)

Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.
by: Antoniades, C, et al.
Published: (2016)

Baseline blood pressure and hypersomnolence predict bp fall with CPAP treatment of OSA
by: Robinson, G, et al.
Published: (2007)

Leukoaraiosis on MRI in patients with minimally symptomatic obstructive sleep apnoea.
by: Schulz, U, et al.
Published: (2013)

OSA: Treatments beyond CPAP
by: Giovanni Cammaroto, et al.
Published: (2022-10-01)

Blood pressure variability in OSA – data from four randomised-controlled CPAP-withdrawal trials
by: Lettau, F, et al.
Published: (2017)

The Assessment of Endothelial Dysfunction among OSA Patients after CPAP Treatment
by: Klaudia Brożyna-Tkaczyk, et al.
Published: (2021-03-01)

Effect of CPAP withdrawal on myocardial perfusion in OSA - a randomized controlled trial
by: Schwarz, E, et al.
Published: (2016)

EFFECT OF CPAP TREATMENT FOR OSA ON VISUAL PROCESSING OF DEGRADED WORDS
by: Proudlove, K, et al.
Published: (2012)

Effect of CPAP-withdrawal on blood pressure in OSA: data from three randomized-controlled trials
by: Schwarz, E, et al.
Published: (2016)

Predictors Of continuous positive airways pressure usage at six months in minimally symptomatic patients: further data from the MOSAIC trial
by: Turnbull, C, et al.
Published: (2015)

Can autonomic arousals and neural net EEG analysis predict daytime sleepiness and its response to nCPAP in OSA?
by: Bennett, L, et al.
Published: (1997)

Does either obesity or OSA severity influence the response of autotitrating CPAP machines in very obese subjects?
by: Turnbull, C, et al.
Published: (2015)

Effects of Overnight Supplemental Oxygen on Morning Blood Pressure in a Randomized Controlled CPAP Withdrawal Trial in Patients with OSA
by: Petousi, N, et al.
Published: (2018)

Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA).
by: Robinson, G, et al.
Published: (2008)

Cardiovascular Risk in Asymptomatic OSA
by: Kohler, M, et al.
Published: (2009)

COVID-19 related changes in outpatient CPAP set-up pathways for OSA are linked with decreased 30-day CPAP usage
by: Turnbull, CD, et al.
Published: (2021)